2020 / 01

Next Paper
DOI: 10.24075/brsmu.2020.004

CLINICAL CASE

Case report: morphological aspects of Buerger's disease

Tsimbalist NS1, Suftin BA2, Kriuchkova AV1, Chupyatova EA1, Babichenko II1
About authors

1 Peoples Friendship University of Russia, Moscow, Russia

2 Central Military Clinical Hospital of the National Guard Troops of the Russian Federation, Balashikha, Russia

Correspondence should be addressed: Natalia S. Tsimbalist
Kuskovskaya, 1–77, Moscow, 111398; ur.tsil@bmiz_n

About paper

Author contribution: Babichenko II, Suftin BA — study concept and design; Suftin BA, Chupyatova EA — data acquisition and processing; Tsimbalist NS, Kriuchkova AV, Babichenko II — manuscript writing; Babichenko II — manuscript editing.

Received: 2019-12-09 Accepted: 2020-01-15 Published online: 2020-01-24
|
  1. Shionoya S, Leu HJ, Lie JT. Buerger’s disease (thromboangiitis obliterans). In: Stehbens WE, Lie JT, eds. Vascular pathology. London: Chapman & Hall Medical, 1995; p. 657–78.
  2. Qaja E, Fortune MA. Buerger Disease (Thromboangiitis Obliterans). StatPearls [Internet]. 2019 Nov [cited 2019 Nov 11]; [about 3 p.]. Available from: https://www.statpearls.com/sp/rn/18685/.
  3. Rivera-Chavarría IJ, Brenes-Gutiérrez JD. Thromboangiitis obliterans (Buerger's disease). Ann Med Surg (Lond). 2016; (7): 79–82. PubMed PMID: 27144003.
  4. Seebald J, Gritters L. Thromboangiitis obliterans (Buerger disease). Radiol Case Rep. 2015; 10 (3): 9–11. PubMed PMID: 26649109.
  5. Li Q-L, He D-H, Huang Y-H, Niu M. Thromboangiitis obliterans in two brothers. Experimental and Therapeutic Medicine. 2013; 6 (2): 317–20. PubMed PMID: 24137181.
  6. Nobre CA, Vieira WP, da Rocha FE, de Carvalho JF, Rodrigues CE. Clinical, arteriographic and histopathologic analysis of 13 patients with thromboangiitis obliterans and coronary involvement. Isr Med Assoc J. 2014; 16 (7): 449–53. PubMed PMID: 25167694.
  7. Shilkina NP, Lileeva MA, Drjazhenkova IV, Kaufman EV, Prokopenko AV. Obliterirujushhij trombangiit i ateroskleroz sosudov nizhnih konechnostej: kliniko-morfologicheskaja harakteristika. Klinicheskaja gerontologija. 2006; 12 (2): 15–18.
  8. Elfarra M, Rădulescu D, Peride I, Niculae A, Ciocâlteu A, Checheriţă IA, et. al. Thromboangiitis obliterans — case report. Chirurgia (Bucur). 2015; 110 (2): 183–7. PubMed PMID: 26011844.
  9. Igari K, Kudo T, Toyofuku T, Inoue Y. Endothelial dysfunction in patients with Buerger disease. Vasc Health Risk Manag. 2017; (13): 317–23. PubMed PMID: 28860792.
  10. Dellalibera-Joviliano R, Joviliano EE, Silva JS, Evora PR. Activation of cytokines corroborate with development of inflammation and autoimmunity in thromboangiitis obliterans patients. Clin Exp Immunol. 2012; 170 (1): 28–35. PubMed PMID: 22943198.
  11. Schmitt J, Schmidt C, Alan C, Haller C, Perrier P. Population genetics, immunologic evaluation and Buerger's disease. Projection through a personal study comprising 127 cases of juvenile arteriopathy. Bull Acad Natl Med. 1993; 177 (7): 1153–64. PubMed PMID: 8149255.
  12. Wan J, Yang Y, Ma ZH, Sun Y, Liu YQ, Li GJ, et al. Autologous peripheral blood stem cell transplantation to treat thromboangiitis obliterans: preliminary results. Eur Rev Med Pharmacol Sci. 2016; 20 (3): 509–13. PubMed PMID: 26914127.
  13. Zerbino DD, Zimba EA, Bagrij NN. Obliterirujushhij trombangiit (bolezn' Bjurgera): sovremennoe sostojanie problemy. Angiologija i sosudistaja hirurgija. 2016; 22 (4): 185–92.
  14. Sinclair NR, Laub DR. Thromboangiitis Obliterans (Buerger's Disease). Eplasty [Internet]. 2015 [cited 2015 Apr 10]; [about 6 p.]. Available from: http://www.eplasty.com/interesting-cases/3591- thromboangiitis-obliterans-(buerger's-disease)
  15. Guzel E, Topal E, Yildirim A, Atilla P, Akkus M, Dagdeviren A. Targeting novel antigens in the arterial wall in thromboangiitis obliterans. Folia Histochem Cytobiol. 2010; 48 (1): 134–41. PubMed PMID: 20529829.